Search by Drug Name or NDC

    NDC 33342-0002-07 Lamivudine 300 mg/1 Details

    Lamivudine 300 mg/1

    Lamivudine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is LAMIVUDINE.

    Product Information

    NDC 33342-0002
    Product ID 33342-002_9e19f010-5f8a-4582-8d49-c385698d9996
    Associated GPIs 12106060000330
    GCN Sequence Number 049905
    GCN Sequence Number Description lamivudine TABLET 300 MG ORAL
    HIC3 W5J
    HIC3 Description ANTIVIRALS, HIV-SPECIFIC, NUCLEOSIDE ANALOG, RTI
    GCN 15709
    HICL Sequence Number 010215
    HICL Sequence Number Description LAMIVUDINE
    Brand/Generic Generic
    Proprietary Name Lamivudine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lamivudine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name LAMIVUDINE
    Labeler Name Macleods Pharmaceuticals Limited
    Pharmaceutical Class Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090198
    Listing Certified Through 2024-12-31

    Package

    NDC 33342-0002-07 (33342000207)

    NDC Package Code 33342-002-07
    Billing NDC 33342000207
    Package 30 TABLET, FILM COATED in 1 BOTTLE (33342-002-07)
    Marketing Start Date 2019-05-02
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.29184
    Pricing Unit EA
    Effective Date 2022-02-23
    NDC Description LAMIVUDINE 300 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis